1. Successful Surgical Resection and Chemotherapy for Unresectable Hepatoblastoma With Pulmonary Metastases and for Lung Recurrence After Liver Transplantation: A Case Report.
- Author
-
Takase, Koki, Ueno, Takehisa, Yamamichi, Taku, Iwasaki, Shun, Toyama, Chiyoshi, Okada, Yosuke, Nomura, Motonari, Watanabe, Miho, Sawada, Akihisa, Miyamura, Takako, Bessho, Kazuhiko, Inoue, Masami, Usui, Noriaki, and Okuyama, Hiroomi
- Subjects
- *
LIVER transplantation , *SURGICAL excision , *REOPERATION , *CANCER relapse , *HEPATOBLASTOMA , *HEPATOCELLULAR carcinoma - Abstract
• Here we present a rare case report of a successful case of hepatoblastoma with pulmonary metastases in which recurrences were treated with repeated lung resection, chemotherapy, and living donor liver transplantation. • Liver transplantation following resection of pulmonary metastases was a feasible option. • Resection of recurrent pulmonary lesions after liver transplantation was a feasible option when lesions were located only in the lung. Liver transplantation (LTx) is indicated for unresectable hepatoblastoma (HB) without distal metastasis. However, to our knowledge, there is no consensus on the management of unresectable HB with pulmonary metastases, or on the treatment of recurrent HB. We report a successful case of metastatic HB treated with repeated lung resection, chemotherapy, and LTx. This study strictly complied with the Helsinki Congress and the Istanbul Declaration regarding donor source. Our case was a 1-year-old boy who developed pre-treatment extent of disease (PRETEXT) Ⅲ HB with multiple pulmonary metastases. The liver tumor was unresectable because it involved all hepatic veins. After 3 cycles of chemotherapy (cisplatin/carboplatin plus doxorubicin), the remaining 2 pulmonary metastases were resected and living donor liver transplantation (LDLT) was performed. Five months after LDLT, a tumor recurrence was detected in the right lung. Repeat lung resection was performed followed by 1 cycle of chemotherapy (carboplatin plus doxorubicin). There has been no recurrence for 18 months since the last lung resection. Previous reports revealed that 14 patients, including the present case, underwent LTx after resection of metastatic HB pulmonary lesions. Of these patients, the 2-year survival rate after LTx was 91%. Recurrence was reported in 5 patients, 2 of whom were successfully treated with repeated resection of the metastatic lesions. LTx after resection of lung recurrence may be a potential treatment for unresectable HB with pulmonary metastases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF